Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial
Conclusions: Lipid-lowering pretreatment is not associated with adverse outcome in AIS patients treated with intravenous alteplase, whether assessed by 90-day death and disability or death alone.Cerebrovasc Dis 2018;45:213 –220
Source: Cerebrovascular Diseases - Category: Neurology Source Type: research
More News: Activase | Cholesterol | Disability | Hemorrhagic Stroke | Hypertension | Ischemic Stroke | Neurology | Statin Therapy | Stroke | Study | Women